Literature DB >> 8645312

Inhibition of Aspergillus serine proteinase by Streptomyces subtilisin inhibitor and high-level expression of this inhibitor in Pichia pastoris.

A Markaryan1, C J Beall, P E Kolattukudy.   

Abstract

Aspergillus fumigatus encodes an extracellular serine proteinase of the subtilisin family that is thought to be involved in invasive aspergillus infection of immunocompromised patients. When the structure of proteinase K was used to model this Aspergillus serine proteinase, Streptomyces subtilisin inhibitor (SSI) was predicted to be capable of binding to the serine proteinase. SSI purified from S. albogriseolus inhibited the serine proteinase with Ki of 1 x 10(-9)M. This value is higher than that for subtilisin probably because the serine proteinase lacks the S(4-6) site that interacts with the P(4-6) site of SSI. A high level expression for SSI, established in Pichia pastoris, yielded 0.5g of SSI per liter of culture medium. The secreted product was easily purified to homogeneity and biochemically characterized. The recombinant SSI showed a Ki of 1.1 x 10(-9) and 1 x 10(-8) for the serine proteinases from A. fumigatus and A. flavus, respectively.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8645312     DOI: 10.1006/bbrc.1996.0412

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Prokaryote-derived protein inhibitors of peptidases: A sketchy occurrence and mostly unknown function.

Authors:  Tomasz Kantyka; Neil D Rawlings; Jan Potempa
Journal:  Biochimie       Date:  2010-06-14       Impact factor: 4.079

2.  Disruption of the serine proteinase gene (sep) in Aspergillus flavus leads to a compensatory increase in the expression of a metalloproteinase gene (mep20).

Authors:  M V Ramesh; P E Kolattukudy
Journal:  J Bacteriol       Date:  1996-07       Impact factor: 3.490

Review 3.  Recombinant protein expression in Pichia pastoris.

Authors:  J M Cregg; J L Cereghino; J Shi; D R Higgins
Journal:  Mol Biotechnol       Date:  2000-09       Impact factor: 2.860

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.